Liu, J., & Shi, H. (2023). IMP-1 inhibits renal cell carcinoma 786-O cell growth by targeting EphrinB2 signaling pathway.
Citación estilo ChicagoLiu, Juan, y Hong Shi. IMP-1 Inhibits Renal Cell Carcinoma 786-O Cell Growth By Targeting EphrinB2 Signaling Pathway. 2023.
Cita MLALiu, Juan, y Hong Shi. IMP-1 Inhibits Renal Cell Carcinoma 786-O Cell Growth By Targeting EphrinB2 Signaling Pathway. 2023.
Precaución: Estas citas no son 100% exactas.